Genentech Rumors, , including commentary and archival articles

Genentech Rumors, , including commentary and archival articles published in The New York Times. S. Dec 6, 2010 · Discover the latest news about our company, our products, our policies, and our people. The company, a member of the Roche Group, has headquarters in South San Francisco, California. [20][21] Genentech's research collaborations include: In 2008 Genentech entered into a collaboration with Roche and its subsidiary GlycArt to develop obinutuzumab. Find out how we're dedicated to giving more patients hope for the future. Genentech More than Doubles Investment in Holly Springs, North Carolina Manufacturing Facility Genentech will more than double the initial investment in a state-of-the-art biomanufacturing facility in Holly Springs to approximately $2 billion, bolstering Roche and Genentech’s $50 billion investment in U. 15, comes after Genentech fired more than 500 employees in the last 15 months. The company, a biotech stalwart owned by the pharmaceutical giant Roche, announced Read our formal press statements on significant topics and events. Genentech’s latest layoffs are the second round of workforce reductions this year, following the company’s announcement in April that it was letting go around 3% of employees. Genentech previously said the use of the drug in the indication accounts for a fraction of its overall revenue from Gavreto in the United States, according to Blueprint. The Aug 27, 2024 · Genentech, a stalwart of Bay Area biotech, is laying off 93 workers not long after a larger cut. Cytokinetics committed an unforced error that has extended the review of its heart disease drug, knocked down its stock price, and triggered the ire of investors. Roche and Genentech are embarking on an ambitious clinical trial of their investigational Alzheimer's drug without waiting for data from key ongoing studies. Find recent and archived press releases. Genentech, Inc. Genentech is letting go of 87 employees at its South San Francisco headquarters, the second round of layoffs at the Roche subsidiary in as many months. The dismissals, which were filed last week and are effective Sept. Our latest campaign shows that our greatest breakthroughs aren’t confined to the lab. 4, revealed that 141 employees were laid off across the pharma’s operations. In a WARN notice posted on the state’s website Genentech is letting go of 143 employees who are based out of the company's headquarters in South San Francisco. Oct 28, 2025 · Genentech plans to cut another 118 jobs in South San Francisco, including data science roles, as biotech industry grapples with funding downturn and AI advancements. Gilead, Genentech and other Bay Area drugmakers are waiting for FDA approvals on their therapies. Genentech, a biotechnology company that pledged last year to build a manufacturing facility in southern Wake County, said it will double its investment here. com is a resource with information in clear and understandable language about clinical trials where Roche/Genentech is doing or supporting research. As Roche braces for the biosimilar assault on blockbuster cancer drugs, its Genentech unit is parting ways with 223 staffers in California. Roche's Genentech said on Tuesday it will more than double its initial investment in a biomanufacturing facility in North Carolina to about $2 billion, as the companies look to further boost their About Genentech Founded nearly 50 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. stock news by MarketWatch. com Add a Comment Roche's Genentech Inc sued Biogen MA Inc on Tuesday in San Francisco federal court, claiming Biogen owes additional patent royalties from worldwide sales of its blockbuster multiple-sclerosis and A Genentech internal review of misconduct allegations concerning a landmark paper co-authored by the now-president of Stanford found no evidence of fraud. Company and product news, including the latest on the biotechnology company. Genentech plans to lay off 118 employees from its South San Francisco campus starting next month, the latest workforce reduction at the prominent Bay Area biotech firm. Genentech is supporting tomorrow's scientists today with innovative new STEM education programs. The Roche Genentech, one of the largest biotechnology companies in the world, announced that it will be shuttering its Vacaville plant, located about 30 minutes outside Sacramento, which has existed since Genentech and Sanofi are laying off hundreds of workers as the biotech giants wind down operations at facilities in South San Francisco. manufacturing and R&D The data underscore Genentech’s commitment to advance patient outcomes in lymphoma with long-term follow-up of its approved medicines Polivy® (polatuzumab vedotin-pi “Some of the soundbite health care policy proposals that candidates bring up for short-term political impact could in practice have consequences,” writes Genentech executive Fritz Bittenbender.